Compare EXG & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EXG | AXGN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2006 | 2013 |
| Metric | EXG | AXGN |
|---|---|---|
| Price | $9.89 | $50.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $42.33 |
| AVG Volume (30 Days) | 438.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.57 |
| Revenue Next Year | N/A | $16.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $8.25 | $14.79 |
| 52 Week High | $10.16 | $51.06 |
| Indicator | EXG | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.06 | 62.72 |
| Support Level | $9.44 | $29.48 |
| Resistance Level | $10.16 | N/A |
| Average True Range (ATR) | 0.09 | 2.17 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 18.86 | 86.76 |
Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.